Physician profile
Anna Shtymak
NPI 1629367727
$3,467.37
in general payments reported to CMS, 2019-2025
22 companies · $735 in 2025
The $735 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $534 · 2023: $971 · 2024: $1,226 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,933.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $567.76 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $458.87 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $442.66 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $374.90 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Novartis Pharmaceuticals Corporation | $337.55 | 2022-2024 | |
| Axsome Therapeutics, INC. | $202.56 | 2024-2025 | Auvelity |
| Glaxosmithkline, LLC. | $186.67 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $138.00 | 2022-2024 | |
| Pfizer INC. | $101.39 | 2024-2025 | |
| Abbott Laboratories | $82.29 | 2023-2024 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $80.03 | 2023-2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $79.55 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $72.12 | 2023-2025 | Caplyta |
| Exact Sciences Corporation | $71.59 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.43 | 2022-2024 | Xifaxan |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $54.21 | 2022-2024 | Evenity, Prolia |
| Astellas Pharma US INC | $49.10 | 2024 | Veozah |
| Inari Medical, INC. | $34.22 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Dexcom, INC. | $24.26 | 2023 | Dexcom G6 Transmitter |
| Regeneron Healthcare Solutions, INC. | $22.69 | 2024 | Evkeeza |
| Baxter Healthcare | $14.73 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Merck Sharp & Dohme LLC | $12.79 | 2023 | Verquvo, Belsomra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Shtymak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.